Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Merck & Co. Inc. buy Barclays PLC

Merck & Co. Inc.

Start price

€103.80

/ 50%

Target price

20.02.27

Performance (%)

Price

Summary

This prediction is currently active. The BUY prediction by Barclays_PLC is currently unchanged from the start price. This prediction currently runs until 20.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction

Performance without dividends (%)

Name	1w
Merck & Co. Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Barclays_PLC for this prediction

In the thread Merck & Co. Inc. diskutieren

Prediction Buy

Perf. (%)

Target price 119.084

Change

Ends at

Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $140.00 price target on the stock.

Ratings data for MRK provided by MarketBeat

0

Stopped prediction by Barclays_PLC for Merck & Co. Inc.

Merck & Co. Inc.

Start price

Target price

Perf. (%)

€103.80

21.02.27

-

50%

Merck & Co. Inc.

Start price

Target price

Perf. (%)

€98.90

07.10.25

50%

Merck & Co. Inc.

Start price

Target price

Perf. (%)

€104.60

31.07.25

50%

Merck & Co. Inc.

Start price

Target price

Perf. (%)

€116.60

02.02.25

50%

Merck & Co. Inc.

Start price

Target price

Perf. (%)

€108.20

23.01.25

50%